Navigation Links
Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting

f choice, and nurturing a unique company culture. Additional information on Hana Biosciences can be found at www.hanabiosciences.com.

The Hana Biosciences, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3290

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that could cause Hana's actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as "anticipates," "expects," "plans," "believes," "intends," and similar words or phrases. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements. Among other things, there can be no assurances that any of Hana's development efforts relating to Talvesta or its product candidates will be successful. Other risks that may affect forward-looking information contained in this press release include the possibility of being unable to obtain regulatory approval of Hana's product candidates, the risk that the results of clinical trials may not support Hana's claims, Hana's reliance on third-party researchers to develop its product candidates, and its lack of experience in developing and commercializing pharmaceutical products. Additional risks are described in the company's Annual Report on Form 10-K for the year ended December 31, 2006 filed with the Securities and Exchange Commission. Hana assumes no obligation to update these statements, except as required by law.

-0- CONTACT: Hana Biosciences, Inc. Invest
'"/>




Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences Announces New Research Studies Presented at APSS Reveal Significant Under-Diagnosis of Insomnia
2. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
3. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
4. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone

Post Your Comments:
(Date:11/6/2009)...C., Nov. 6 The ,Help ...h Carolina and Georgia throughout the week of Nove...ured and financially-struggling patients access in...dicines for free or nearly free. With the nation,s...artnership for Prescription Assistance (PPA) bus t...
(Date:11/6/2009).... 6 NuVasive, Inc. (Nasd...eveloping products for minimally disruptive surgic...ppointment of Michael J. Lambert as Executive Vice...November 9, 2009. The Company also announced seve... "Michael will be an excellent complement to the N...
(Date:11/6/2009)...toba, Nov. 6 With his proposed hea...et his sights on cutting name-brand prescription d...fall into the "Part D" coverage gap, universally k...t the potential cost-cutting and feel it,s a promi...most powerful lobbyists want a revised program tha...
Breaking Medicine Technology:Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Seattle Suttons Healthy Eating Opens Arizona Franchise 51710 1Seattle Suttons Healthy Eating Opens Arizona Franchise 51710 2Seattle Suttons Healthy Eating Opens Arizona Franchise 51710 3Seattle Suttons Healthy Eating Opens Arizona Franchise 51710 4Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 1Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 2Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 3Heart Defect Spotted During Surgery May Not Need Repair 51702 1Heart Defect Spotted During Surgery May Not Need Repair 51702 2
(Date:11/8/2009)...8 Pharmaceutical Resear...e President Ken Johnson released the following sta...: ,, "We are disappointed, but not surprised by...of hardworking Americans as well as nearly half of...who voted against the bill. ,, "While well inte...
(Date:11/8/2009)... Shows Who Sides With Working Families vs. Insuran...swire-USNewswire/ -- On the heels of an historic l... a good, balanced health care reform bill, the Pen...state,s U.S. representatives voted on HR 3962, the...e legislation, which passed Saturday evening by a ...
(Date:11/7/2009)...v. 7 Speaker Nancy Pel....R. 3962, the Affordable Health Care for America A...tonight. Below are the Speaker,s remarks. ,, ...ric moment for our nation and for American familie...nd political philosophy -- as far back as Teddy Ro...
(Date:11/7/2009)...PRNewswire/ -- Calling this a "defining moment" fo...President J. James Rohack, M.D., today addressed m...te and medical specialty societies at the opening ...ere health system reform will top the agenda. ,...81209/AMALOGO ) ,, "Over the next 72 hours, t...
(Date:11/7/2009)...7 The U.S. bishops Nove...es to vote for the Stupak-Ellsworth Amendment to t...-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment ... funding and conscience protections in the Afforda... said. ,, The letter was signed by Cardinal Jus...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2
...Alseres Pharmaceuticals, Inc. today announced that...ASDAQ Stock Market ("NASDAQ") that for the last 10... listed securities has been below the minimum $35 ...NASDAQ Marketplace Rule 4310(c)(3)(A) or 4310(c)(3...
...scular group practice to use Sage Intergy solution...ition itself for pay-for-performance , , TAMPA, F...scular Institute, a Saginaw-Mich.-based group prac...(PM) and Sage Intergy EHR electronic health reco...
...eveal targets for future treatments , , MO...they have discovered genes in prostate cancer cell...th each other, an occurrence that may initiate the...cer cells, a finding that may serve as a marker fo...
...an Inc. (Nasdaq: MYL ),today announced that its ...onal U.S. patents protecting the company,s Perforo... pulmonary disease (COPD) treatment. , U.S. Pa...ormoterol. This patent covers Dey,s Perforomist(R)...
...publication of its kind aimed at healthcare fraud ...e Insight(R) (HCI), a Verisk HealthCare company an... and overpayment prevention solutions for healthca...lication dedicated to helping public and private s...
... Boehringer Ingelheim today announced the appoint...Sales and Marketing for the company,s Prescription...ad the U.S. sales and marketing strategy of Boehri...ef Executive Officer, Boehringer Ingelheim Corpora...
Other Medicine News:Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 2Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 3Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 4Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 2Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 3Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 4Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 5Health News:U.S. Patent and Trademark Office Issues Mylan's Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution 2Health News:HealthCare Insight(R) Launches Industry Fraud Magazine 2Health News:Boehringer Ingelheim Appoints Albert Ros as Executive Vice President of Sales and Marketing for Prescription Medicines 2
RNA1c Control for Bayer DCA 2000 and 2000 + Analyzers
Molteno3 Glaucoma Drainage Device
...s a reagent and probe system used together to quan...t plate based system is a sandwich nucleic acid hy...for RNA detection and quantification, by amplifyin...chnology. Branched DNA allows immediate quantifica...
Cormet Hip Resurfacing System
Medicine Products: